Objective To describe the incidence of injuries and illnesses sustained during the Tokyo Summer Olympic Games from 23 July to 8 August 2021.
Methods We recorded the daily number of athlete injuries and illnesses (1) through the reporting of all National Olympic Committee (NOC) medical teams and (2) in the polyclinic and medical venues by the Tokyo 2020 medical staff.
Results In total, 11 315 athletes (5423 women, 48%; 5892 men, 52%) from 206 NOCs were followed up prospectively for the occurrence of injury and illness. NOC and Tokyo 2020 medical staff reported 1035 injuries and 438 illnesses, equalling 9.1 injuries and 3.9 illnesses per 100 athletes over the 17-day period. Altogether, 9% of the athletes incurred at least one injury and 4% at least one illness. The incidence of injury was highest in boxing (27%), BMX racing (27%), BMX freestyle (22%), skateboarding (21%), karate (19%) and handball (18%), of which both BMX freestyle and skateboarding were new events, and lowest in diving, road cycling, rowing, marathon swimming and shooting (1–2%). Marathon and artistic swimming presented the highest illness incidences (both 8%), followed by skateboarding and karate (both 7%). In the study period, COVID-19 affected 18 athletes, accounting for 4% of all illnesses and 0.16% of all athletes. Exertional heat illness affected 78 athletes (18% of all illnesses, 0.7% of all athletes), the majority (88%) resulting in no time lost from sport.
Conclusion Overall, 9% of the athletes incurred an injury and 4% an illness during the Games. Comprehensive countermeasures helped mitigate both COVID-19 and exertional heat illnesses.
- Sporting injuries
Data availability statement
No data are available.
This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
WHAT IS ALREADY KNOWN ON THIS TOPIC
Elite athletes gain a number of health benefits, but run a high risk of musculoskeletal injuries and other disorders during and after their sporting careers
WHAT THIS STUDY ADDS
Overall, 9% and 4% of the athletes incurred at least one injury or illness, respectively, during the Tokyo 2020 Olympic Games
Boxing (27%), BMX racing (27%), BMX freestyle (22%), skateboarding (21%), karate (19%) and handball (18%) were the sports with the highest incidences of injury
COVID-19 and a hot and humid environment presented considerable challenges for the athletes and the organisation of the Games, but both were mitigated through comprehensive countermeasures
HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE OR POLICY
Athlete medical staff and event organisers can plan and optimise their healthcare provision, and, more importantly, prevention measures according to the diagnoses and risk profile of their athlete populations
Reaching the highest level in sport requires athletes to commit to thousands of hours of deliberate and intense training. The extreme nature of their line of work, striving to outperform their peers through relentlessly pushing their physical and mental boundaries,1 also means that many oscillate between being either almost injured or injured throughout their careers. While athletes benefit from greater life expectancy and lower risk of chronic disease and hospital admission compared with the general population,2–5 they do run a high risk of injuries and musculoskeletal disorders throughout,1 6–11 and after the end12–15 of their sporting career.
Protecting the health of the athletes is one of the main priorities of the International Olympic Committee (IOC),16 and the IOC has surveyed the sports injuries and illnesses in every Olympic Games since Beijing 2008.6–11 The overall proportion of injured athletes has ranged from 10% to 14% and ill athletes from 5% to 9%; however, there have been large variations between sports. The Tokyo 2020 Summer Olympics introduced several new sports and disciplines, including baseball/softball, karate, skateboarding, sport climbing, surfing, 3×3 basketball and BMX freestyle.
The main challenge facing the Tokyo Olympics was the outbreak of the global COVID-19 pandemic, which had forced postponement of the Games by 1 year. Ensuring the successful running of the Olympic Games while at the same time protecting the health and safety of both athletes and the general public was a monumental and unprecedented undertaking.17–19 In addition, a hot and humid Tokyo summer presented both athletes and the event organisers with an additional challenge from both a sporting and health protection point of view.20–22
Our aim in this study was to describe the incidence and characteristics of the sports injuries and illnesses occurring during the Tokyo 2020 Summer Olympics.
We employed the IOC injury and illness surveillance system for multi-sport events in this prospective cohort study as used in previous Games.23 Notably, the 2020 IOC consensus statement on methods for recording and reporting injury and illness data in sport was not published until after preparation for this study was completed.24 We invited all National Olympic Committee (NOC) medical teams to report the daily occurrence (or non-occurrence) of athlete injuries and illnesses using an electronic report form (side module of General Electric Athlete Management Solution; GE AMS). Concurrently, we retrieved the same information on all athletes treated for injuries and illnesses in the polyclinic and all other medical venues operated by the Tokyo Organising Committee of the Olympic and Paralympic Games (Tokyo 2020/OCOG) medical staff. These data were collected through an electronic medical record system (GE AMS).
The day before the opening of the Games we organised a meeting for all NOC medical staff. At this meeting we informed them about the protocol, answered questions, created user accounts for the GE AMS injury and illness reporting system and distributed tablet computers to facilitate their daily reporting.
Throughout the data collection, we actively followed up with frequent visits to the NOCs whose team sizes were 10 athletes or larger (respecting COVID-19 countermeasures) and electronic contact to deal with any questions and encourage continuous reporting during the games. We recorded the response rate (and injuries and illnesses) of all the participating NOCs.
Definition of injury and illness
We defined injuries and illnesses as new (pre-existing, not fully rehabilitated conditions were not recorded) or recurring (athletes having returned to full participation after a previous condition) incurred in competition or training during the period between the opening and closing ceremonies of the Olympic Games Tokyo 2020 (23 July to 8 August 2021) receiving medical attention, regardless of the consequences with respect to absence from competition or training. Injuries comprised musculoskeletal complaints, concussions and other non-musculoskeletal trauma. Illnesses were defined as complaints or disorders not related to injury. In cases where a single incident caused multiple injury types, we recorded only the most severe diagnosis—as determined by our research team based on all available clinical data—for analysis. We defined injury and illness severity by the number of estimated days lost from training or competition. In the interest of presenting complete data on COVID-19 in athletes at the Games, we also report all confirmed cases occurring before the opening of the Games (from the day the athletes arrived at the airport in Tokyo), but do not include these in the analyses overall and per sport (to avoid skewing the results in comparison with past and future Games).
Injury and illness report form
Our injury and illness report form followed the template of that used in the Vancouver 2010, London 2012, Sochi 2014, Rio 2016 and PyeongChang 2018 Olympic Games. With respect to injuries, we recorded the following data: accreditation number, name, sport and event, whether the injury occurred in competition or training, date and time, body part, type, cause and estimated time lost from competition or training. We recorded data on illnesses in a similar fashion: accreditation number, sport and event, date, affected system, main symptom(s), cause and estimated time loss.
We provided instructions and examples on how to complete the form correctly. Furthermore, the report form was available in nine languages: English, French, Arabic, Chinese, German, Japanese, Korean, Russian and Spanish.
Confidentiality and ethical approval
In addition to the aforementioned variables, we queried the IOC athlete database for the age and sex of the injured or ill athlete. We treated all information confidentially, and deidentified our database after the Games, ensuring anonymity of all athletes.
The study was reviewed by the Medical Research Ethics Committee of the South-Eastern Norway Regional Health Authority (2011/388).
Patient and public involvement
Patients were not involved in the planning or execution of the study. Representatives of the patients (the athletes) will be invited to help interpret the results and their relevance and potential for future injury and illness prevention measures.
Equity, diversity and inclusion statement
Our study population includes all athletes participating in the Olympic Games. Our author group includes mixed genders (five women, six men), continents (Europe, South America, North America, Asia), nationalities (NOR, UK, GER, BRA, RUS, JPN, IRL, CAN), ages and professional backgrounds, as well as representation from two former Olympians (DP and RB).
In cases where athletes were treated for the same condition by both the NOC and Tokyo 2020 medical staff, we retained the most complete data source. Unless more precise clinical data were available, we set the estimated days of absence from sport for confirmed COVID-19 cases to 10 days, based on the average isolation time in place during the Games.
We calculated the summary measures of injury and illness incidences (i) according to the formula i=n/e, where n is the number of injuries or illnesses in competition, training or in total during the study period and e the respective number of exposed (participating) athletes; with incidence proportions presented as injuries/illnesses per 100 athletes. We also calculated the summary measures of injury and illnesses per 1000 athlete-days, where athlete-days correspond to the total number of athletes multiplied by 17 days. We calculated confidence intervals of the risk ratio (RR) of the number of injuries or illnesses between two groups by a simple Poisson model, assuming constant hazard per group and adjusting for sport, sex, age and/or NOC size (by the number of athletes), where appropriate. We present injury and illness incidences as means and risk ratios with 95% confidence intervals. We regarded two-tailed p values <0.05 as significant.
In total, 11 315 athletes took part in the Tokyo Olympic Games. Of these, 5423 were women (48%) and 5892 men (52%). Ten athletes participated in two different sports, giving a total of 11 325 athlete exposures to injury or illness.
Throughout the 17 days of the Games, the 206 NOCs submitted 1866 of maximal 3502 daily reports (53%; 94 countries did not submit any data) (table 1). The response rate of the 108 NOCs with ≥10 participating athletes (accounting for 96% of all the athletes) was 95% (1752 of 1836 reports).
Injuries overall, by sport and sex
We recorded a total of 1035 injuries, equalling 9.1 injuries (95% CI 8.6 to 9.7) per 100 participating athletes. This corresponds to 5.4 injuries per 1000 athlete-days. Overall, 9% (n=964) of the athletes sustained at least one injury. Of these, 45 athletes sustained two injuries, and one athlete sustained three injuries.
Figure 1 shows the incidence proportion of injured athletes in each sport (additional details are available in online supplemental appendix 1). The incidence of injury was highest in boxing (27.1 injuries (95% CI 21.1 to 33.1) per 100 athletes), BMX racing (27.1 (12.4 to 41.8)), BMX freestyle (22.2 (0.4 to 44.0)), skateboarding (21.0 (11.0 to 31.0)), karate (18.5 (9.1 to 27.9)) and handball (17.8 (13.4 to 22.3)), and lowest in diving, road cycling, rowing, marathon swimming and shooting (ranging from 1 to 2 injuries per 100 athletes).
When adjusting for sport, age and NOC size, there was no difference in overall injury incidence between women (8.6 injuries (95% CI 7.8 to 9.4) per 100 athletes) and men (9.6 (8.8 to 10.4), RR=0.93 (0.83 to 1.06), online supplemental appendix 1). However, female athletes were at significantly higher risk of injury in artistic gymnastics (RR=3.20 (1.17 to 8.74)), while at lower risk in baseball/softball (RR=0.19 (0.04 to 0.81)) and boxing (RR=0.43 (0.24 to 0.75)).
Severity of injuries
While 56% of the injuries were estimated to result in no time loss from sport (n=583), 44% (n=124) were expected to entail ≥1 day of time loss from competition or training (online supplemental appendix 1). It was estimated that 24% of the injuries (n=247) would result in an absence from sports from 1 to 7 days, 11% (n=113) in an absence from 8 to 28 days, and 9% (n=92) in an absence for more than 28 days. Figure 1 shows the incidence of injuries estimated to lead to ≥1 day and >7 days of absence in each sport. Box 1 presents the details of the 205 injuries with >7 days of time loss.
Information on the 205 injuries with estimated absence >7 days, with the sports with the highest numbers in brackets.
43 muscle strains grade 1 or 2 (25 in athletics, 2 each in rugby, weightlifting, fencing and tennis).
33 ligament sprains grade 1 or 2 (7 in judo, 6 in wrestling, 3 in football, 2 each in indoor volleyball and athletics).
20 acute fractures (5 in boxing, 3 in rugby, 2 in taekwondo, 2 in track cycling).
17 joint dislocations/subluxations (5 in handball, 3 in rugby, 2 in judo).
13 bone contusions (3 in boxing, 2 each in judo and taekwondo).
12 muscle ruptures grade 3 (5 in athletics, 3 in football).
11 lesions of meniscus or cartilage (2 in fencing).
10 ligament ruptures grade 3 (2 each in judo, rugby and team handball).
7 stress fractures/reactions (5 in athletics).
6 skin lesions/lacerations (3 in boxing, 2 in athletics).
6 concussions (2 in hockey).
5 tendon ruptures grade 3 (3 in athletics).
5 tendinopathies (3 in athletics).
4 tendon sprains grade 1 or 2 (2 in athletics).
4 joint synovitis/arthritis/bursitis.
3 muscle contusions/haematoma.
1 fasciitis/aponeurosis injury.
1 joint impingement.
Details missing for four injuries.
Location and type of injuries
The most commonly injured locations were the knee (n=114), posterior thigh (n=89), shoulder (n=88), ankle (n=86) and face (including eyes, ears and nose; n=80). The most common injury types were skin laceration/lesion/abrasion (n=133), muscle strain grade 1 or 2 (n=119) and ligament sprain grade 1 or 2 (n=113). The distributions of injury locations and injury types per sport are presented in online supplemental appendixes 2, 3, respectively.
Causes, mechanisms and onset of injury
While 77% (n=793) of the injuries occurred acutely, 12% (n=121) and 10% (n=101) were chronic or recurrent, respectively (information missing for 20 injuries). In terms of aetiology, the most commonly reported injury mechanisms were contact with another athlete (26%), non-contact trauma (20%), overuse with sudden onset (14%) and overuse with gradual onset (12%); details for each sport are available in online supplemental appendix 4.
Fifty-eight per cent of the injuries were sustained in competition, 34% during training and 7% during warm up or cool down (information missing for 11 injuries; details for each sport are presented in online supplemental appendix 1).
Illnesses overall, by sex, sport and severity
A total of 438 illnesses were reported, resulting in 3.9 illnesses (95% CI 3.5 to 4.2) per 100 athletes. This corresponds to 2.3 illnesses per 1000 athlete-days. On average, 4% (n=420) of the athletes incurred an illness, as 16 athletes incurred two illnesses and one athlete reported three illnesses. When controlling for sport, age and NOC size, women (4.6 illnesses (95% CI 4.0 to 5.1) per 100 athletes) were at significantly greater risk of experiencing an illness than men (3.2 (2.8 to 3.7), RR=1.51 (1.25 to 1.82), online supplemental appendix 1).
Figure 2 shows the incidence proportion of illness in each sport (additional details are available in online supplemental appendix 1). Marathon swimming had the highest illness incidence (7.8 illnesses (95% CI 0.2 to 15.5) per 100 athletes), followed by artistic swimming (7.7 (2.4 to 13.0)), skateboarding (7.4 (1.5 to 13.3)), and karate (7.4 (1.5 to 13.3)). Conversely, no illnesses occurred in 3×3 basketball, mountain bike cycling and modern pentathlon.
One in five illnesses (n=80, 18%) were expected to result in absence from training or competition. In artistic swimming, five out of the eight illnesses were estimated to entail >7 days of absence (online supplemental appendix 1).
Affected system, aetiology of illness and COVID-19
The most affected organ systems/regions were the dermatologic (n=83, 19%), thermoregulatory (n=78, 18%), respiratory (n=75, 17%) and gastrointestinal (n=63, 14%) systems.
Of the 75 respiratory illnesses, 45 were caused by infection (10% of all illnesses, 0.4% of the athletes incurred a respiratory infection), of which 18, in turn, were SARS-CoV-2 infections (4% of all illnesses, 0.16% of the athletes). In addition to the cases occurring during the study period (23 July to 8 August 2021), 15 confirmed cases occurred before the Games started (ie, from arrival at the airport until the Opening Ceremony of the Games), giving a total of 33 cases of COVID-19 in athletes (0.29% of the athletes).
With respect to the thermoregulatory illnesses, all reported cases (n=78, 18% of all illnesses, affecting 0.7% of all athletes across all sports) were exercise-induced heat illnesses; the majority resulting in no time loss from sport (n=69, 88%). Nine cases were estimated to lead to time loss from sport: seven (9% of all heat illnesses) entailing 1 day of absence and two (3% of all heat illnesses) entailing 3 days of absence.
The distribution of affected systems, main symptoms and aetiology of illness per sport are presented in online appendices 5, 6 and 7, respectively.
Data sources, and injuries and illnesses per NOC size
Only 13% of all injuries and 4% of all illnesses were captured by both the NOCs and the Tokyo 2020 staff. While 39% of the injuries and 40% of the illnesses were recorded solely by the NOCs, 48% and 56% of the injuries and illnesses, respectively, were recorded solely by the Tokyo 2020 staff (table 1).
The incidence of injury and illness tended to be lowest for NOCs with >99 athletes, and when adjusting for sport, sex and age, there was an inverse relationship between NOC size and the incidence of illness, with athletes from smaller NOCs having more illnesses (NOCs with <10 athletes: 8.5 (95% CI 5.9 to 11.2) illnesses per 100 athletes versus NOCs with >99 athletes: 3.1 (2.8 to 3.5) illnesses per 100 athletes (RR=2.97 (2.12 to 4.18)).
Injuries in existing and new Olympic sports
The aim of this paper was to describe the athlete injuries and illnesses which occurred during the Tokyo 2020 Olympic Games. The incidence of injury in the Tokyo Olympics (9%) was comparable to those in the Summer Games of Beijing 2008 (10%),11 London 2012 (11%)9 and Rio 2016 (8%).7
Comparison of each sport in Tokyo 2020 with those in Rio 2016 showed that the incidences of injury in Tokyo were higher in table tennis (12% vs 3% of the athletes injured), but lower in diving (1% vs 9%), water polo (11% vs 19%), mountain biking (7% vs 24%), road cycling (2% vs 6%), football (8% vs 15%) and tennis (4% vs 11%).
Many of the new sports and disciplines on the Olympic programme had a high incidences of injury. Of all the sports in Tokyo, BMX freestyle had the third highest injury incidence (22% of the athletes injured), skateboarding the fourth highest (21%) and karate the fifth highest (19%). Sport climbing (15%), surfing (13%), 3×3 basketball (11%), and baseball/softball (8%) were around the middle third for injury incidences. BMX freestyle, karate, sport climbing and 3×3 basketball were tested 4 years earlier during the Buenos Aires 2018 Youth Olympic Games. There, the incidence proportions were 13% in karate, 2% in sport climbing and 18% in 3×3 basketball (data unavailable for BMX freestyle).25
A change in the incidence of injury can result from a multitude of factors, including, but not limited to, changes in the composition of the Olympic Games programme, environmental and weather conditions, venue or track design, competition rules, equipment, awareness and adherence to injury prevention training, injury and illness recording methods, and in the skill level and adherence of the medical staff recording the data.26 27 This emphasises the importance of ongoing, longitudinal monitoring of injuries and illnesses as such variables might change over time.
COVID-19 in the Games
The Tokyo Olympic Games were postponed by 1 year due to the outbreak of the global COVID-19 pandemic in early 2020. By spring 2021, based on comprehensive collaboration between Tokyo 2020, the IOC, International Paralympic Committee (IPC), Government of Japan, Tokyo Metropolitan Government, a designated task force of scientific experts and organisations from across the world, the Tokyo Olympic Games playbooks were developed and implemented.28 These COVID-19 mitigation policies and regulations outlined the responsibilities of all Games participants starting 14 days before travelling to the Games, when entering Japan, at the Games and when leaving Japan. Key public health principles included mandated mask wearing; minimisation of physical interaction; testing, tracing and isolating; and enhanced personal hygiene (hand washing). Athletes from all participating NOCs were also offered vaccine doses ahead of the Games, with a vaccination rate of 85% among Olympic Village residents.29 For testing, participants were required to provide proof of two negative PCR tests before departing for Tokyo, another negative test on arrival and then daily screening tests throughout the Games. The goals of these COVID-19 countermeasures were to ensure both the successful running of the Games and the safety and health of Games participants and of the people of Japan.
The effectiveness of the countermeasures is reflected in our results. The overall incidence of illness (3.9 illnesses per 100 athletes) was the lowest we have recorded in the Games; lower than in PyeongChang 2018 (9.4),6 Rio 2016 (5.4),7 Sochi 2014 (8.9),8 London 2012 (7.2)9 and Vancouver 2010 (7.2).10 This effect was induced primarily by a substantial reduction in respiratory infections (0.4% of the athletes incurred a respiratory infection) compared with all previous Games (4.8% in PyeongChang, 1.9% in Rio, 4.2% in Sochi, 1.9% in London, 1.1% in Vancouver). Importantly, only a small fraction of the participating athletes contracted COVID-19 (0.16% of the athletes, 0.29% of the athletes if including cases reported before the Opening Ceremony of the Games), of which all cases were imported as athletes arrived in Japan, with no spread to the local population.30 While contracting COVID-19 was potentially devastating for some of the athletes in question as the required time in isolation prevented their possible lifetime Olympic participation, the small number of COVID-19 positive tests was a result of the concerted countermeasures by all stakeholders involved, allowing the successful running of the Games.
Exertional heat illnesses during the Games
During the Olympic Games, Tokyo experienced high ambient temperatures (>30°C) and relative humidity (>70%),31 limiting both the convective and evaporative capacity of the athletes to dissipate heat. It has been shown that intense and prolonged exercise under such conditions can lead some athletes to reach core body temperatures exceeding 40°C.32 Educational material on heat acclimatisation—one of the most effective countermeasures to protect the athlete’s health and performance before competing in a hot environment33—was developed and widely circulated to the athletes to aid their preparation for the Games.34 Training in the heat for about 2 weeks triggers physiological adaptations allowing for better thermoregulation, reducing the cardiovascular stress and increasing the exercise capacity in the heat.35 Before the Games, two events (marathon and race walking) were relocated 800 km north to Sapporo, which is normally 4–5°C cooler than Tokyo. However, during Games time, it was equally hot and humid there.31 Other events were rescheduled to cooler mornings or evenings (eg, women’s football final). There were also a range of important venue heat mitigation strategies in place before, during and after competition, including the provision of hydration, shading, air conditioning, fans, ice packs, mist sprays and precooling and recovery ice baths. For medical management, specific medical algorithms were developed for high heat stress venues with the goal of early recognition and diagnosis, rapid on-site cooling and advanced clinical care.36 Although we nonetheless recorded 78 cases of exertional heat illness in the Games—including diagnoses of heat stroke, exhaustion, syncope and heat-related muscle cramps—the mitigation measures probably played a crucial role in reducing their severity, with the majority (88%) being mild with no estimated time loss from sport.
Our methodology closely followed the 2020 IOC consensus statement on the recording and reporting of sport injuries and illnesses,24 but there were some differences in the taxonomy of data variables (such as for injury types and illness organ systems). By the time the 2020 IOC consensus was published, our study preparations were too far advanced (including electronic medical record software development, system documentation, translations to other languages and medical staff training) to economically justify additional changes.
In studies on sports injury, it is usually recommended that incidences are expressed using a measure of time exposed to risk as the denominator.24 37 However, considering the inherent complexity and size of the Olympic Games, this was not feasible in this study. Instead, we expressed the injuries or illnesses as the number of new cases per 100 exposed athletes (incidence proportion). This approach erroneously assumes that the frequencies and lengths of exposure are identical in all sports and that the number of athletes at risk in each NOC is constant throughout the Games, resulting in an overestimation of exposure and an accompanying underestimation of the incidence of injury and illness. This effect was probably compounded by one of the Tokyo 2020 COVID-19 countermeasures mandating athletes to arrive late and/or leave early. Interpretation of differences in incidences or patterns of injury, and comparisons with other studies must therefore be made with caution.
In the current study we included new or recurring injuries or illnesses receiving medical attention. By using this definition, gradual onset and less serious health problems might be overlooked, since they do not always require medical attention,24 38–40 although our results show that the majority of reported injuries and illnesses were estimated not to entail any time loss.
Unless more precise clinical data were available, we set the estimated days of absence from sport for confirmed COVID-19 cases to 10 days, based on the average isolation time in place during the Games. In cases where symptoms fully resolved either before or after the 10 days had passed this would either overestimate or underestimate, respectively, the reported severity.
We asked both the NOC and the Tokyo 2020 medical personnel to record all injuries and illnesses for all athletes seen; however, only 13% of the injuries and a mere 4% of the illnesses were captured by both, underlining the importance of recording data from both groups. As it is possible that some cases were captured neither by the NOCs nor the Tokyo medical staff, our results probably underestimate the true incidence of injuries and illnesses.
We have presented the proportions of injury and illness incidence (figures 1 and 2; Online supplemental appendix 1), as well as the detailed clinical information (injury and illness types, locations, aetiology, etc; online supplemental appendixes 2–7) for all the sports in the Tokyo 2020 Olympics. Our results can help both team athlete medical staff and event organisers plan and optimise their healthcare provision, and, more importantly, their prevention measures according to the diagnoses and risk profile of their athlete populations. For example, based on these results, a BMX cyclist’s need for medical care and prevention measures is different from that of a marathon swimmer, demonstrated by their distinct injury and illness profiles (frequencies, clinical presentations, degrees of severity, etc). Importantly, the international federations governing the sports with high incidences of injury and illness, including the sports new to the Olympic programme, must use these data with an aim of reducing the risk in future events.
It is evident that the COVID-19 pandemic and the hot and humid environment each in their own way presented considerable challenges for the athletes, support staff and the overall organisation of the Games. Our results indicate that both factors were substantially mitigated through the comprehensive countermeasures developed for the Games. The success of these mitigation programmes speaks to the potency of all relevant stakeholders (ie, event organisers, governments, scientific experts and organisations, athletes and their entourage) coming together through deliberate collaboration and planning, providing a legacy strategy for future events. However, preventing a problem is better than solving it. While little could have been done to prevent the COVID-19 pandemic, it would be beneficial for the athletes, organising committee and all other stakeholders if future Summer Olympic Games could be held in cooler environments better suited for intense physical exertion. This will reduce the need for resources to implement exertional heat illness countermeasures (from both event organisers and the athletes) and maximise the athletes’ chances of safely reaching their peak performance.
In summary, 9% of the athletes were injured and 4% ill during the Tokyo 2020 Summer Olympic Games. While the incidence of injury was similar to that of previous Games, the incidence of illness was lower. This might largely be attributed to the extensive countermeasures in put place to mitigate COVID-19, effectively reducing transmission of COVID-19 and all respiratory infections. Heat and humidity posed a challenge to athletes, support teams and organisers, but exertional heat illnesses were mitigated through a host of cooling and hydration strategies. Some of the new sports on the Olympic programme had high incidences of injury. Our results can inform both the planning of future Olympic Games and similar events, the provision of healthcare for athletes in such events, as well as further research on understanding why the most frequent injuries and illnesses occur, and how to prevent them in the future.
Data availability statement
No data are available.
Patient consent for publication
This study involves human participants but the study was reviewed (and exempted, based on being regarded as an audit) by the Medical Research Ethics Committee of the South-Eastern Norway Regional Health Authority (2011/388). All data are deidentified. Participants were informed about the study through two information notices delivered when they applied for their Olympic Games accreditation and when seeking treatment in the medical stations in the Games.
The authors would like to acknowledge the contribution and support of the Tokyo 2020 and GE Healthcare staff throughout the different stages of this study. The authors also sincerely thank the National Olympic Committee medical staff who contributed to the data collection: Dr. Ferrial Chouiter (ALG), Dr. Manuela Veloso (ANG), Dr. Carina Estela Rua (ARG), Dr. Carlos Eduardo Marino (ARG), Dr. Estanislao Salas (ARG), Dr. Fernando Locaso (ARG), Dr. Juan Jose Dere (ARG), Dr. Nestor Lentini (ARG), Dr. Davit Mosinyan (ARM), Dr. Caroline O'Brien (AUS), Dr. David Hughes (AUS), Dr. John Azoury (AUS), Dr. Ruth Fazakerley (AUS), Dr. Joachim Westermeier (AUT), Dr. Zaur Abdullayev (AZE), Dr. Carl Ward (BAR), Dr. Johan Bellemans (BEL), Dr. Iryna Maliovanaya (BLR), Dr. Kagiso Tlhabano-David (BOT), Dr. Mmoloki Maswabi (BOT), Dr. Sithabile Machao (BOT), Dr. Ana Carolina Ramos E Corte (BRA), Dr. André Pedrinelli (BRA), Dr. Breno Schor (BRA), Dr. Felipe Hardt (BRA), Dr. Marco Michelucci (BRA), Dr. Ronaldo Aguiar (BRA), Dr. Tathiana Parmigiano (BRA), Dr. Khaled Ali (BRN), Dr. Ivan Ivanov (BUL), Dr. Jessica Curran (CAN), Dr. Michael Koehle (CAN), Dr. Mike Wilkinson (CAN), Dr. Prasad Navin (CAN), Dr. Sari Kraft (CAN), Dr. Susan Labrecque (CAN), Dr. Teresa Defreitas (CAN), Dr. Prudent Madjidanem (CHA), Dr. Diego Amenabar (CHI), Dr. Ignacio Solar (CHI), Dr. Jing Li (CHN), Dr. Lawrence Teariki Puni (COK), Dr. César Mauricio Ruiz Padilla (COL), Dr. Jorge Andres Perez Sandoval (COL), Dr. Juan Diego Parraga (COL), Dr. Mauricio Serrato (COL), Dr. Ruvy Rodriguez (COL), Dr. Gustavo Adolfo Castillo Quirós (CRC), Dr. Dinko Pivalica (CRO), Dr. Castillo Diaz Pablo (CUB), Dr. Karolina Velebova (CZE), Dr. Christoffer Brushøj (DEN), Dr. Laura Pinedo Carrasco (DOM), Dr. Sánchez Lisette (DOM), Dr. Pablo Sarmiento (ECU), Dr. Yasser Hosny Abdelrahman (EGY), Dr. Sameh Salem (EGY), Dr. Carlo Bagutti (EOR), Dr. Jenna Muellauer (EOR), Dr. Medhanie Ytbarek (ERI), Dr. Tesfaselassie Eyob Gebreamlak (ERI), Dr. Carmen Vaz (ESP), Dr. Gonzalez Santander Manuela (ESP), Dr. Juan F Abellan (ESP), Dr. Manuela Gonzalez Santander (ESP), Dr. Mariana Morales (ESP), Dr. Rafael Arriaza (ESP), Dr. Urena Rosario (ESP), Dr. Mihkel Mardna (EST), Dr. Hiwot Mengistu (ETH), Dr. Kalkidan Zegeye Hailemariam (ETH), Dr. Jone Bakabaka Nasome (FIJ), Dr. Maarit Valtonen (FIN), Dr. Philippe Le Van (FRA), Dr. Niall Elliott (GBR), Dr. Zurab Kakhabrishvili (GEO), Dr. Bernd Wolfarth (GER), Dr. Casper Grim (GER), Dr. Christine Kopp (GER), Dr. Manfred Giensch (GER), Dr. Wolfgang Herb (GER), Dr. Jonathan Quartey (GHA), Dr. Julia Derban (GHA), Dr. Odysseas Paxinos (GRE), Dr. Julio Motta-Pensabene (GUA), Dr. Julian Wai Chang (HKG), Dr. Jozsef Toman (HUN), Dr. Carmen Shiran Yunita Jahja (INA), Dr. Kumar Bhowmik (IND), Dr. Gholamreza Norouzi (IRI), Dr. Reza Saeedi (IRI), Dr. Seyed Ashkan Ordibehesht (IRI), Dr. Anthony Clove (IRL), Dr. Frank O’ Leary (IRL), Dr. George Fuller (IRL), Dr. James O'Donovan (IRL), Dr. Louise O'Connell (IRL), Dr. Stuart O'Flanagan (IRL), Dr. Lubov Galitskaya (ISR), Dr. Flavia Santoboni (ITA), Dr. Lincoln A. Cox (JAM), Dr. Khalid Al Mahd (JOR), Dr. Akiko Uchda (JPN), Dr. Akira Ikumi (JPN), Dr. Hideki Takeda (JPN), Dr. Hiroshi Kamada (JPN), Dr. Kohei Nakajima (JPN), Dr. Kohjiroh Imoto (JPN), Dr. Marie Iwamatsu (JPN), Dr. Michiko Dohi (JPN), Dr. Mika Hangai (JPN), Dr. Mikihiko Hattori (JPN), Dr. Nami Yamaguchi (JPN), Dr. Nobukazu Okimoto (JPN), Dr. Satoshi Iwao (JPN), Dr. Sayaka Motojima (JPN), Dr. Takashi Tsukahara (JPN), Dr. Takefumi Sakaguchi (JPN), Dr. Takeshi Kamitani (JPN), Dr. Tomofumi Nishino (JPN), Dr. Tomohiko Tateishi (JPN), Dr. Tomohiro Manabe (JPN), Dr. Azamat Nurmatov (KAZ), Dr. Carole Okuth (KEN), Dr. Sarah Karongo (KEN), Dr. Sospeter Kinuthia Kori (KEN), Dr. Chul-Won Ha (KOR), Dr. Sejun Kim (KOR), Dr. Saleh Alharthi (KSA), Dr. Fatema Hayat (KUW), Dr. Liga Cirule (LAT), Dr. Dalius Barkauskas (LTU), Dr. Christian Nührenbörger (LUX), Dr. Amine Dorhmi (MAR), Dr. Ismail Bouzekraoui Alaoui (MAR), Dr. Kamarul Hashimy Hussein (MAS), Dr. Maia Toncoglaz (MDA), Dr. Toncoglaz Maia (MDA), Dr. Viridiana Deyanira Silva Quiroz (MEX), Dr. Ganzolboo Buyantogtokh (MGL), Dr. Kirill Micallef Stafrace (MLT), Dr. Predrag Dabovic (MNE), Dr. Maarten Moen (NED), Dr. Gabriel Olanrewaju Oyegunna (NGR), Dr. Paul Onyeudo (NGR), Dr. Thomas Torgalsen (NOR), Dr. Bruce Hamilton (NZL), Dr. Alex Almengor (PAN), Dr. Grerys Soto (PAN), Dr. Miguel Arce Paredes (PER), Dr. Randolph Molo (PHI), Dr. Luis Cruz (PLW), Dr. Kapua Kapua (PNG), Dr. Matthew Natusch (PNG), Dr. Hubert Krysztofiak (POL), Dr. Krzesimir Sieczych (POL), Dr. Jose Pereira (POR), Dr. Quintas Filipe (POR), Dr. Fernando Luis Sepulveda Irizarry (PUR), Dr. Luis Baerga (PUR), Dr. Rebecca Rodriguez Negron (PUR), Dr. El Sanfaz Laith Anis (QAT), Dr. Laith Anis ElSanfaz (QAT), Dr. Andrey Zholinskii (ROC), Dr. Maxim Velichko (ROC), Dr. Vasile Osean (ROU), Dr. Craig Thompson (RSA), Dr. Danielle Lincoln (RSA), Dr. Gavin Shang (RSA), Dr. Livhuhani Crosby Mulungwa (RSA), Dr. Phathokuhle Zondi (RSA), Dr. Tshegofatso Gaetsewe (RSA), Dr. Sibomana Rusika Emmanuel (RWA), Dr. Martin Rodríguez Barrios (SEY), Dr. Chin Sim Teoh (SGP), Dr. Matjaz Vogrin (SLO), Dr. Goran Vasic (SRB), Dr. Nikola Čikiriz (SRB), Dr. Himan De Silva Himan De Silva (SRI), Dr. Priyanka Perera Prageeth (SRI), Dr. Daniel Wegmann (SUI), Dr. Patrik Noack (SUI), Dr. Daniel Knaze Dolezalova (SVK), Dr. Roman Fano (SVK), Dr. Per Andersson (SWE), Dr. Numchai Rattanapongbundit (THA), Dr. Paisal Chantarapitak (THA), Dr. Siripoj Sribunditkul (THA), Dr. Yinchou Lin (TPE), Dr. Nailah Adams (TTO), Dr. Dorsaf Metani (TUN), Dr. Ahmet Mustafa Ada (TUR), Dr. Abdulla Alrahoomi (UAE), Dr. Nana Jacqueline Nakiddu (UGA), Dr. Igor Olexenko (UKR), Dr. Daniel Zarrillo (URU), Dr. Alan Shahtaji (USA), Dr. Alexandra Myers (USA), Dr. Amber Donaldson (USA), Dr. Ariel Nassim (USA), Dr. Cathy Arnot (USA), Dr. Christina Yannetsos (USA), Dr. Commander Cody (USA), Dr. Daryl Osbahr (USA), Dr. David Kruse (USA), Dr. David Taylor (USA), Dr. David Weinstein (USA), Dr. Dionne Calhoun (USA), Dr. Elmo Agatep (USA), Dr. Jennifer Carrol (USA), Dr. Jill Stutts (USA), Dr. John Fierro (USA), Dr. Jonathan Finnoff (USA), Dr. Jonathan Fow (USA), Dr. Kara Michelle Kessans (USA), Dr. Kevin Kotsko (USA), Dr. Marcia Faustin (USA), Dr. Mark Hutchinson (USA), Dr. Matthew Collins (USA), Dr. Michele Latimer (USA), Dr. Mindy Siegel (USA), Dr. Monica Rho (USA), Dr. Naresh Rao (USA), Dr. O. Josh Bloom (USA), Dr. Shelby Hoppis (USA), Dr. Susan Bromley (USA), Dr. Talena Williams (USA), Dr. Thomas Mick (USA), Dr. Warren Flautt (USA), Dr. Zachary Dicristino (USA), Dr. Azamjon Soliev (UZB), Dr. Manuel Alberto Figueiras Olazabal (VEN), Dr. Ninoska Clocier (VEN), Dr. Van Phu Nguyen (VIE), Dr. Titus Suranga Fernando Waduruwalage (ZAM), Dr. Abigail Mnikwa (ZIM).
Twitter @DebbiePalmerOLY, @margomountjoy, @larsengebretsen
Contributors All authors contributed to the study conception and design, data collection and interpretation. TSo analysed the data and drafted the paper. All authors provided revisions and contributed to the final manuscript. TSo is the guarantor.
Funding The International Olympic Committee funded the data collection of the study.
Competing interests TSo works as scientific manager in the Medical and Scientific Department of the International Olympic Committee. KS is co-editor of the British Journal of Sports Medicine – Injury Prevention & Health Protection. MM is deputy editor of the British Journal of Sports Medicine. RB is director of the Medical and Scientific Department of the International Olympic Committee. LE is head of scientific activities in the Medical and Scientific Department of the International Olympic Committee, and editor of the British Journal of Sports Medicine and associate editor of the Journal of Bone and Joint Surgery.
Patient and public involvement Patients and/or the public were involved in the design, or conduct, or reporting, or dissemination plans of this research. Refer to the Methods section for further details.
Provenance and peer review Not commissioned; externally peer reviewed.
Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.